November 5 2020 7:09 pm Join Us For A Conversation Between Lisa Genova & Greg O’Brien: Dec 1st, 5:30 PM
October 23 2020 VARIATION IN TAU AMONG ALZHEIMER’S PATIENTS MAY EXPLAIN WHY SOME PEOPLE DECLINE AT A FASTER RATE THAN OTHERS
October 23 2020 AMYLYX PHARMACEUTICALS ANNOUNCES COMPLETION OF ENROLLMENT IN THE PEGASUS TRIAL OF AMX0035 IN ALZHEIMER’S DISEASE
October 23 2020 FDA Approves First Tau Imaging Agent For PET Scans For Diagnosis of Alzheimer’s Disease
October 23 2020 How Assessing Blood-Brain Barrier Damage in APOE4 Carriers May Predict Cognitive Decline